Methyl 4-chlorothiazole-5-carboxylate

Catalog No.: 
ACVIJC587
CAS No.: 
1015591-57-7
Molecular Formula: 
C5H4ClNO2S
Molecular Weight: 
177.61
Methyl 4-chlorothiazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$286.00InquiryInquiry
250mg97%$357.00InquiryInquiry
1g97%$762.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-chlorothiazole-5-carboxylate
IUPAC Namemethyl 4-chlorothiazole-5-carboxylate
MDL No.MFCD10478283
Molecular FormulaC5H4ClNO2S
Molecular Weight177.61
SMILESO=C(C1=C(Cl)N=CS1)OC
InChI KeyCFFMCXJJYDGJCF-UHFFFAOYSA-N
SynonymMethyl 4-chlorothiazole-5-carboxylate;4-Chloro-thiazole-5-carboxylic acid methyl ester;5-Thiazolecarboxylic acid, 4-chloro-, methyl ester
CAS No.1015591-57-7
PubChem CID24219261

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVIJC587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAHPU820 route compound structure diagram
    ACAHPU820861708-66-9In Stock
  2. Then
  3. ACVIJC587 route product structure diagram
    ACVIJC5871015591-57-7
Inquiry

2. ACVIJC587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACSNLZ028 route compound structure diagram
    ACSNLZ028444909-59-5In Stock
  4. Then
  5. ACVIJC587 route product structure diagram
    ACVIJC5871015591-57-7
Inquiry

3. ACVIJC587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVIJC587 route product structure diagram
    ACVIJC5871015591-57-7
Inquiry

Comments (0)